Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents

Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775 Chalasani, 2018, The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases, Hepatology, 67, 328, 10.1002/hep.29367 Farrell, 2006, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology, 43, S99, 10.1002/hep.20973 Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Ayonrinde, 2011, Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease, Hepatology, 53, 800, 10.1002/hep.24097 Younossi, 2019, Non-alcoholic fatty liver disease - a global public health perspective, J Hepatol, 70, 531, 10.1016/j.jhep.2018.10.033 Schwimmer, 2006, Prevalence of fatty liver in children and adolescents, Pediatrics, 118, 1388, 10.1542/peds.2006-1212 Lawlor, 2014, Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents, J Clin Endocrinol Metab, 99, E410, 10.1210/jc.2013-3612 Song, 2017, Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese children, Int J Environ Res Public Health, 14, 465, 10.3390/ijerph14050465 Doycheva, 2017, Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic, Hepatology, 65, 2100, 10.1002/hep.29068 Welsh, 2013, Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010, J Pediatr, 162, 496, 10.1016/j.jpeds.2012.08.043 2018 2018 Wong, 2018, The association between nonalcoholic fatty liver disease and cardiovascular disease outcomes, Clin Liver Dis (Hoboken), 12, 39, 10.1002/cld.721 Alkhouri, 2011, Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease, Clin Lipidol, 6, 305, 10.2217/clp.11.19 Allen, 2018, Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study, Hepatology, 67, 1726, 10.1002/hep.29546 Joshi, 2016, Remnant lipoprotein cholesterol and incident coronary heart disease: the Jackson heart and Framingham offspring cohort studies, J Am Heart Assoc, 5, e002765, 10.1161/JAHA.115.002765 Pastori, 2018, Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease, J Clin Med, 7, 378 Huang, 2013, Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents, Hepatology, 58, 1306, 10.1002/hep.26495 Hartley, 2018, Metabolic profiling of adolescent non-alcoholic fatty liver disease, Wellcome Open Res, 3, 166, 10.12688/wellcomeopenres.14974.1 Newnham, 1993, Effects of frequent ultrasound during pregnancy: a randomised controlled trial, Lancet, 342, 887, 10.1016/0140-6736(93)91944-H Straker, 2017, Cohort profile: the Western Australian pregnancy cohort (raine) study-generation 2, Int J Epidemiol, 46, 1384 Alberti, 2006, Metabolic syndrome--a new world-wide definition. A consensus statement from the International Diabetes Federation, Diabet Med, 23, 469, 10.1111/j.1464-5491.2006.01858.x Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Motamed, 2017, Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases, Clin Res Hepatol Gastroenterol, 41, 31, 10.1016/j.clinre.2016.07.005 Targher, 2010, Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease, N Engl J Med, 363, 1341, 10.1056/NEJMra0912063 Assy, 2010, Presence of coronary plaques in patients with nonalcoholic fatty liver disease, Radiology, 254, 393, 10.1148/radiol.09090769 Wu, 2016, Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis, Sci Rep, 6, 33386, 10.1038/srep33386 Adams, 2017, Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases, Gut, 66, 1138, 10.1136/gutjnl-2017-313884 Francque, 2016, Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications, J Hepatol, 65, 425, 10.1016/j.jhep.2016.04.005 Alexander, 2019, Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults, BMJ, 367, l5367, 10.1136/bmj.l5367 Nakamura, 2011, Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals, Atherosclerosis, 218, 163, 10.1016/j.atherosclerosis.2011.04.040 Nguyen, 2017, Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease, J Cardiol, 69, 529 2016, EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease, J Hepatol, 64, 1388, 10.1016/j.jhep.2015.11.004